Abnormalities of smooth pursuit in Parkinson's disease: A systematic review - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 17:4:100085.
doi: 10.1016/j.prdoa.2020.100085. eCollection 2021.

Abnormalities of smooth pursuit in Parkinson's disease: A systematic review

Karen Frei  1
Affiliations
Review

Abnormalities of smooth pursuit in Parkinson's disease: A systematic review

Karen Frei. Clin Park Relat Disord. .

Abstract

Smooth pursuit eye movement (SPEM) abnormalities are commonly seen in Parkinson's disease (PD). Both reduced speed and saccades seen during SPEM, also known as saccadic pursuit (SP), have been studied in PD. A comprehensive literature review analyzed 26 studies of SPEM and PD. It appears that a greater proportion of PD patients have SPEM abnormalities consisting of reduced SPEM gain and/or SP compared to the normal population. It is not clear whether SPEM abnormalities are present early in the disease or begin sometime during disease progression. SPEM abnormalities may be correlated with disease severity but do not fluctuate or respond to dopaminergic medication in the same manner as other motor symptoms in PD. SPEM in PD is composed of normal SPEM interspersed with SP composed of both catch up and anticipatory saccades. This differs from other neurodegenerative disorders and may be related to an inability to inhibit extraneous saccades or to increased distraction reflecting executive dysfunction. Because the basal ganglia are involved in SPEM physiology, degeneration of the SNr neurons in PD may explain abnormal SPEM in this disorder. Since dementia, aging and medication effects influence SPEM, they should be controlled for in future studies of SPEM in PD. SP is easily detected on clinical exam and may be a biomarker for the disease or for disease progression. Oculomotor testing can be an important part of the Parkinson's exam.

Keywords: Oculomotor abnormalities; Parkinson’s disease; Saccadic pursuit; Smooth pursuit eye movements.

PubMed Disclaimer

Conflict of interest statement

Nothing to declare.

Figures

Fig. 1
Fig. 1
Methods of SPEM literature review.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Corin M.S., Elizan T.S., Bender M.B. Oculomotor function in patients with Parkinson's disease. J. Neurol. Sci. 1972;15:251–265. - PubMed
    1. Cipparrone L., Ginanneschi A., Degl’Innocenti F., Porzio P., Pagnini P., Marini P. Electro-oculographic routine examination in Parkinson’s disease. Acta Neurol. Scand. 1988;77:6–11. - PubMed
    1. Nakamura T., Kanayama R., Sano R., Ohki M., Kimura Y., Aoyagi M., Koike Y. Quantitative analysis of ocular movements in Parkinson's disease. Acta Otolaryngol. 1991;111(Suppl. 481):559–562. - PubMed
    1. Armstrong R.A. Oculo-visual dysfunction in Parkinson’s disease. J. Parkinson. Dis. 2015;5:715–726. - PMC - PubMed
    1. Shibasaki H., Tsuji S., Kuroiwa Y. Oculomotor abnormalities in Parkinson's disease. Arch. Neurol. 1979;36:360–364. - PubMed

Further reading

    1. Westheimer G. Eye movement responses to a horizontally moving visual stimulus. Arch. Ophthalmol. 1954;52:932–941. - PubMed

LinkOut - more resources